AF
QTTB icon

Amalgamated Financial’s Q32 Bio QTTB Stock Holding History

Amalgamated Financial’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$15K Buy
+282
New +$17.5K ﹤0.01% 2822

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Amalgamated Financial's QTTB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Q32 Bio (QTTB) in Q1 2022: 282 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2822 among its holdings.

106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • Amalgamated Financial held 282 shares of Q32 Bio worth $15K as of Q1 2022.
  • Q32 Bio was a new Amalgamated Financial position in Q1 2022.
  • Q32 Bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2822 holding.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.